Mohawk Industries (MHK) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
25 Dec, 2025Executive summary
Q1 2025 net sales were $2.53 billion, down 5.7% year-over-year, with adjusted EPS at $1.52, supported by productivity gains, restructuring, and a lower tax rate, partially offsetting pricing pressure and higher input costs.
Flooring North America order system conversion caused a $50 million sales and $30 million operating income impact, but service levels have normalized.
Tariffs on Chinese imports are expected to add $50 million in annualized costs, with mitigation planned via price increases and supply chain adjustments.
Inventory increased by $80 million due to pre-tariff imports; free cash flow was negative $85 million in Q1 but is expected to improve.
225,000 shares repurchased for $26 million during the quarter.
Financial highlights
Gross margin was 23.1% as reported, 24.1% excluding charges, in line with prior year; adjusted EBITDA margin was 10.6%.
Adjusted operating income was $122 million (4.8% margin), down from $163 million (6.1%) a year ago.
Interest expense fell to $6 million, reflecting lower debt and higher interest income.
Free cash flow was negative $85 million in Q1, expected to improve for the year.
Net debt at quarter-end was $1.68 billion; net debt to adjusted EBITDA ratio at 1.2x.
Outlook and guidance
Q2 2025 adjusted EPS guidance is $2.52–$2.62, excluding restructuring or one-time charges.
Restructuring actions are expected to yield $100 million in annual savings in 2025, with some savings extending into 2026.
Management expects continued pricing pressure, soft demand, and inflation, but is optimistic about long-term flooring demand recovery as interest rates decline.
CapEx for 2025 is planned at $530 million, focused on capacity and cost reduction.
Latest events from Mohawk Industries
- Q4 2025 net sales rose 2.4% to $2.7B; 2026 outlook expects improved sales and earnings.MHK
Q4 202527 Feb 2026 - Q2 adjusted EPS up 9% as cost actions and cash flow offset weak sales and market pressures.MHK
Q2 20242 Feb 2026 - Q3 2024 adjusted EPS up 7% to $2.90; 2025 recovery expected as rates decline.MHK
Q3 202418 Jan 2026 - Adjusted EPS steady at $1.95 as cost actions offset weak demand; $285M savings targeted.MHK
Q4 20249 Dec 2025 - Proxy covers director elections, auditor ratification, executive pay, and ESG priorities.MHK
Proxy Filing1 Dec 2025 - Q3 2025 sales up 1.4% to $2.8B, with $110M in savings and ongoing cost actions amid soft demand.MHK
Q3 202524 Oct 2025 - Flat Q2 2025 sales, margin pressure, and a $500M buyback amid ongoing cost and tariff risks.MHK
Q2 202525 Jul 2025